Literature DB >> 10758225

Molecular mechanisms of vascular permeability in diabetic retinopathy.

D A Antonetti1, E Lieth, A J Barber, T W Gardner.   

Abstract

Diabetes leads to a wide array of complications in humans, including kidney failure, vascular disease, peripheral nerve degeneration, and vision loss. Diabetic retinopathy causes blindness in more working-age people in the United States than any other disease and contributes greatly to blindness in the young and old as well. The increasing rate of diabetes occurring in our society can only bring about a further decrease in the visual health of this country unless new modalities are discovered to prevent and cure diabetic retinopathy. Breakdown of the blood-retinal barrier and the resultant vascular permeability remains one of the first observable alterations in diabetic retinopathy and strongly correlates with vision loss. In this article, we examine the molecular components that form this blood-retinal barrier and explore how changes in the production of growth factors in the neural parenchyma cause an increase in vascular permeability and contribute to retinal degeneration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10758225     DOI: 10.3109/08820539909069543

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  65 in total

1.  Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes.

Authors:  Y Chen; J J Wang; J Li; K I Hosoya; R Ratan; T Townes; S X Zhang
Journal:  Diabetologia       Date:  2012-06-04       Impact factor: 10.122

2.  Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK.

Authors:  Hashem A Dbouk; Lauren M Weil; G K Sachith Perera; Michael T Dellinger; Gray Pearson; Rolf A Brekken; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

Review 3.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

4.  High glucose disrupts mitochondrial morphology in retinal endothelial cells: implications for diabetic retinopathy.

Authors:  Kyle Trudeau; Anthony J A Molina; Wen Guo; Sayon Roy
Journal:  Am J Pathol       Date:  2010-06-03       Impact factor: 4.307

5.  Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model.

Authors:  W-Y Shen; C M Lai; C E Graham; N Binz; Y K Y Lai; J Eade; D Guidolin; D Ribatti; S A Dunlop; P E Rakoczy
Journal:  Diabetologia       Date:  2006-05-10       Impact factor: 10.122

6.  Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema.

Authors:  J K Luttrull; D C Musch; M A Mainster
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

7.  Insights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling.

Authors:  Yunzhou Dong; Xue Cai; Yong Wu; Yanjun Liu; Lin Deng; Hong Chen
Journal:  J Nat Sci       Date:  2017-01

8.  An experimental platform for systemic drug delivery to the retina.

Authors:  Matthew Campbell; Anh T H Nguyen; Anna-Sophia Kiang; Lawrence C S Tam; Oliviero L Gobbo; Christian Kerskens; Sorcha Ni Dhubhghaill; Marian M Humphries; G-Jane Farrar; Paul F Kenna; Peter Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

9.  Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy.

Authors:  Ramaprasad Talahalli; Simona Zarini; Nader Sheibani; Robert C Murphy; Rose A Gubitosi-Klug
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-15       Impact factor: 4.799

10.  5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy.

Authors:  Rose A Gubitosi-Klug; Ramaprasad Talahalli; Yunpeng Du; Jerry L Nadler; Timothy S Kern
Journal:  Diabetes       Date:  2008-03-17       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.